Skip to content

Improved diagnosis of clinically occult breast lesions

Improved diagnosis of clinically occult breast lesions - IDOL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38092
Enrollment
128
Registered
2011-09-27
Start date
2011-11-10
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast neoplasms

Interventions

The studied diagnostic intervention is a vacuum assisted percutaneous intact biopsy of mammographically suspicious breast lesions under stereotactic mammographic guidance. The intervention will be p

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Female gender; - Age >= 18 years; - Nonpalpable mammographically suspicious breast lesion (classified as BIRADS 3-5) requiring stereotactic biopsy.

Exclusion criteria

Exclusion criteria: - Legal incapability; - Insufficient command of the Dutch language; - Contraindication for temporarily stopping anticoagulant therapy; - Inability to maintain a prone position for 1 hour; - Ipsilateral breast implant; - Lactation; - Implanted electronic device;

Design outcomes

Primary

MeasureTime frame
Histological diagnosis issued on the biopsy specimen and the surgical excision specimen, the number of cancelled procedures due to a contra-indication for RFIB and the number of unsuccessful RFIB procedures due to technical failure or a nonrepresentative biopsy sample.

Secondary

MeasureTime frame
A numerical pain score, procedure duration, cosmetic outcome and functional status post RFIB, complication rate, biopsy specimen quality and the chance of complete removal of a lesion.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)